Abstract
Objective
This study aimed to determine the incidence of Ureaplasma urealyticum and Mycoplasma hominis infections in infertile and fertile men and to investigate their effects on the semen quality. The study also aimed to analyze the drug susceptibility of UU and MH to provide guidance for reasonable antibiotic use.
Methods
A total of 19,098 semen specimens were obtained from infertile men at our hospital from January to December 2014. In addition to these specimens, 3368 semen specimens of sperm were obtained from donors at the sperm bank of our hospital from January 2011 to December 2014. Semen analysis was performed using the methods outlined by the World Health Organization.
Results
The prevalence of UU and MH significantly differed between infertile and fertile men. The mean progressive motility, total motility, and normal forms in the semen samples of infertile males positive for UU significantly differed from the corresponding values of uninfected men. However, the semen parameters did not differ between MH-infected and uninfected men. In the antibiotic sensitivity test, UU, MH, and UU mixed with MH were all found susceptible to doxycycline and josamycin with drug resistance rates below 6 %, but both species were highly resistant to ciprofloxacin.
Conclusions
Clinical assessment revealed a significant relationship between UU and MH infections and male infertility. UU was found to significantly affect sperm quality, but this was not the case with MH. Doxycycline and josamycin should be preferred for clinically treating UU and MH infections.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Infertility, defined as the inability to achieve pregnancy after 1 year of regular intercourse [1], affects 15 % of couples in reproductive age. About 10–20 % of the inability to achieve pregnancy can be explained by male infertility and 30–40 % is explained by both male and female infertility [2]. Many factors can cause male infertility, and approximately 15 % of male infertility is associated with the infection in the genital tract [3]. U. urealyticum and M. hominis are commonly found in the genital tract of patients experiencing symptoms including infertility, orchitis, epididymitis, prostatitis, and nongonococcal urethritis [4, 5] as well as in asymptomatic subjects [6, 7].
For about a decade, U. urealyticum and M. hominis infections have been recognized as a common sexually transmitted disease (STD) in developed countries [8]. These microorganisms naturally inhabit the male urethra and contaminate the semen during ejaculation. However, both these microorganisms, particularly U. urealyticum, are potential pathogens that play etiologic roles in both genital infections and male infertility [9, 10]. Several studies have analyzed the relationship between U. urealyticum and M. hominis infections and semen quality, and some have demonstrated that these infections alter various characteristics of semen, such as sperm motility, density, and morphology, and that antibiotic treatment can improve the semen quality [11, 12]. On the contrary, other researchers did not find that U. urealyticum and M. hominis infections affect either semen quality or male infertility [13]. Contrary to the evidence that these microorganisms play an important role in the pathogenesis of human infertility, no convincing causal relationships between the infections and human infertility have yet been established.
In the present study, we examined the prevalence of U. urealyticum and M. hominis infections in infertile and fertile men and their effect on semen quality by analyzing the morphology, semen volume, pH value, sperm concentration, progressive motility, and total motility. Furthermore, the drug resistance of these microorganisms was evaluated.
Materials and methods
Study population
Ethics approval from the regional ethics committee has been granted for the focus groups with infertile and fertile men. A total of 19,098 men of infertile couples who visited the Reproductive Center, the Reproductive and Genetic Hospital of CITIC, Xiangya, China, from January to December 2014 were enrolled in this study. The patients were enrolled for semen analysis following a failure to impregnate their wives after at least 1 year of unprotected sexual intercourse. Past history of infections and sexual history were obtained from all patients. The following exclusion criteria were applied: (1) reproductive system abnormalities, known hereditary and/or familial disorders; (2) heavy alcohol use (>60 g/day); (3) heavy smoking (>20 cigarettes/day); and (4) exposure to physical or chemical agents with known negative reproductive effects. The control group included 3368 fertile men who donated sperm at the sperm bank from January 2011 to December 2014. Men whose semen parameters were normal and/or those whose wives had nonassisted pregnancies in the past were considered fertile.
Ureaplasma urealyticum and M. hominis detection and antimicrobial susceptibility testing
Mycoplasma IST (Crest, China) was used for the detection and antimicrobial susceptibility testing of both microbial species. Urethral samples were fed on lyophilized medium to diagnose U. urealyticum and M. hominis infections and drug susceptibilities. The samples were homogenized by slight rotation. Then, 100 µL of the samples was transferred to microplates containing antibiotics and proliferation wells separately for the qualitative detection of U. urealyticum and M. hominis. One drop of sterile mineral oil was added to each well to generate anaerobic conditions for culture. Microplates were closed with caps and incubated at 37 °C for 24 and 48 h, respectively. For detection, U. urealyticum and M. hominis growth could be detected using the indicator phenol red in the medium. Both strains were tested for susceptibility to thiamphenicol, doxycycline, erythromycin, azithromycin, clarithromycin, josamycin, levofloxacin, ciprofloxacin, roxithromycin, and gatifloxacin.
Semen collection
Semen samples were collected by masturbation into a sterile container after 3–5 days of abstinence. The samples were liquefied at 37 °C for about 30 min in an incubator before analysis.
Semen analysis
The semen was analyzed using the methods outlined by the World Health Organization (WHO, 5th edition), and the volume, pH, progressive motility (PR), total motility (PR + NP), sperm concentration, normal forms, and total motile sperm count (TMC) were determined.
Statistical analysis
SPSS 19.0 statistical software was used for statistical analysis. The results are reported as mean ± standard deviation unless otherwise indicated. The t test and chi-square test were used to compare continuous variables and categorical variables, respectively. A statistically significant difference was defined when the P value was <0.05.
Results
Demographic characteristics
A total of 19,098 semen samples were taken from patients aged 23–44 years (28.6 ± 7.2), individuals in the fertile group were those who were aged 20–35 years (26.9 ± 5.5), no differences were found in the age between fertile and infertile groups (P = 0.16), and the groups did not differ significantly in frequency of sexual intercourse, abstinence times, BMI, alcohol drinking, and smoking (Table 1).
Prevalence of U. urealyticum and M. hominis in infertile and fertile men
The prevalence of these pathogens significantly differed between infertile and fertile men (Table 2). The prevalence of U. urealyticum-positive specimens among urethral specimens in infertile and fertile men was 10.22 % (1951/19,098) and 3.65 % (123/3368; χ 2, 147.203; P < 0.001), respectively. M. hominis was detected in 3.16 % (604/19,098) and 0.89 % (37/3368) of infertile and fertile men, respectively (χ 2 test, 41.490; P < 0.001). Finally, 1.8 (343/19,098) and 0.48 % (16/3368) of fertile men were found to harbor mixed pathogens (χ 2, 31.771; P < 0.001).
Effects of U. urealyticum and M. hominis on semen quality
The semen variables in the infertile and fertile men are summarized in Table 3. The mean values of sperm concentration, progressive motility, total motility, normal forms, and TMC were significantly lower in infertile men than in fertile men. To identify the effects of U. urealyticum and M. hominis on semen, we compared semen parameters of the infected and uninfected subjects. Some of the parameters including sperm concentration, progressive motility, total motility, normal forms, and TMC tended to be lower in the infected group than in the uninfected group, although the differences were not significant in the case of M. hominis-infected and uninfected individuals (P > 0.05; Table 4). The progressive motility, total motility, and normal forms showed significant difference between the U. urealyticum-infected, mixed infection, and uninfected groups (P < 0.05). The TMC was significantly lower in the mixed infection group (P = 0.017) than in the uninfected group.
Drug susceptibility test results
Table 5 presents the antibiotic resistance profiles of each microorganism. As shown in the table, 1857 (95.2 %) and 1851 (94.9 %) of the 1951 patients with U. urealyticum infection were susceptible to doxycycline and josamycin, respectively. Furthermore, 1709 (87.6 %) of the 1951 patients with U. urealyticum infection were resistant to levofloxacin, and 1826 (93.6 %) were resistant to ciprofloxacin. A higher proportion of patients (330/343; 96.2 %) with both U. urealyticum and M. hominis showed higher resistance to ciprofloxacin at higher critical concentrations. Mixed infections were more susceptible to doxycycline and josamycin than either U. urealyticum or M. hominis infection alone. Mixed infections were more resistant to ciprofloxacin.
Discussion
The relationship between U. urealyticum and M. hominis infection and male infertility has been studied widely; however, the results remain controversial. Most patients with these infections are not aware of their infections because they do not experience any symptoms. These inconsistencies are probably because of small sample sizes and confounding factors, such as social and economic factors and sexual activity. Meanwhile, different populations have different susceptibility, which may be also one of the reasons for this controversy. China is one of the most populous countries in the world. The rapid pace of economic and social change in China over the past two decades has been accompanied by an increased rate of infertility [14, 15]. In addition, antibiotic abuse will lead to drug resistance. As a result, the treatment options for U. urealyticum and M. hominis infections are becoming more and more limited. Our study illustrates an important link between the presence of these microorganisms and infertility in men and provides guidance for reasonable use of antibiotics in China.
Although there is considerable disagreement on the exact association of U. urealyticum and M. hominis with male infertility, it is generally agreed that the prevalence of both these infections is higher in infertile men than in fertile men [16–19]. Our study demonstrated a statistically significant higher detection rate of U. urealyticum in the urethral specimens from infertile men (10.22 %) compared to fertile men (3.65 %) and of M. hominis in the urethral specimens from infertile men (3.16 %) compared to fertile men (0.89 %). The detection rates for U. urealyticum and M. hominis in infertile men were approximately threefold higher than the corresponding rates in fertile men. U. urealyticum is the smallest free-living organism that most commonly inhabits the urogenital tract and has been found in male seminal fluids with a prevalence ranging from 10 to 42 % [20, 21]. The high rate of U. urealyticum detection in this study suggests that it is widespread among infertile men, which is consistent with previous findings [16, 17]. The prevalence of M. hominis varies significantly between infertile and fertile men and was low in our study; other studies have also found that M. hominis is uncommon in the urethra of men [22]. We were concerned that technical problems and detection method might have resulted in the low prevalence observed in this study. However, our results were in agreement with the findings reported previously, suggesting that the prevalence of M. hominis in the urethra of the male Chinese population is indeed low. In our study, U. urealyticum and M. hominis were often detected in both infertile and fertile men, suggesting that they may have a commensal relationship.
In addition to studying the prevalence of these microorganisms in infertile and fertile men, we also assessed the relationship of these microorganisms with sperm quality. The semen quality is considered to be one of the most significant indicators of male fertility. Previous studies on the effects of U. urealyticum and M. hominis infections or colonization on semen parameters also show conflicting results. Some studies have reported that these microorganisms have no real effect on the quality of semen [23, 24], but others have demonstrated associations between U. urealyticum and M. hominis and semen quality [10, 25]. In this study, we evaluated the correlation between progressive motility, total motility, and normal forms and U. urealyticum infection in infertile men. Mixed infection of U. urealyticum and M. hominis was found to be associated with lower progressive motility, total motility, normal forms, and TMC. However, although M. hominis infection was associated with a reduction in motility and sperm concentration, we failed to demonstrate any significant correlation between the M. hominis infection and semen quality (P > 0.05). The results of this study are consistent with previous findings [24, 26]. These microorganisms may diminish fertility by adhering to spermatozoa and directly altering sperm morphology, as well as motility and survival [24].
The susceptibilities of genital mycoplasmas to antimicrobial agents differ by geographic region [27]. The difference in the antimicrobial resistance found in reports from various countries might be due to the differences in the guidelines of antimicrobial usage. Our result showed that both U. urealyticum and M. hominis had relatively low resistance to josamycin and doxycycline in China. Similar results were found in recent studies by Yang [28], Chen [29], and Yang [30]. Therefore, josamycin and doxycycline should be the primary choice for U. urealyticum and M. hominis in China.
This study has some limitations. First, the study did not include leukocytes as a variable in the semen parameters. The presence of leukocytes in the semen may be indicative of infection or inflammation; however, there remains controversy about the significance of true leukocytospermia. The role of leukocytes in semen in predicting reproductive performance warrants further study. Second, although the semen volume, pH value, sperm concentration, and other parameters were studied, we did not study the changes in these parameters following antibiotic treatment and we also did not study the pregnancy rates before and after antibiotic treatment; studying the post-treatment changes in these parameters and pregnancy rates may better support our findings. Third, the donated sperm will be chosen for the patients with azoospermia and severe oligozoospermia, but we still included them in the study because the proportion of the patients with azoospermia and severe oligozoospermia was small, and they may still have infections.
At last, U. urealyticum and M. hominis infections may adversely affect the seminal quality in both infertile and fertile men; however, we did not study the seminal quality of fertile men because this study focused primarily on the effects of U. urealyticum and M. hominis infections on the seminal quality of infertile men. Future studies could study the seminal quality of both fertile and infertile men with these infections.
In conclusion, this study revealed that U. urealyticum and M. hominis were widely prevalent in the male population, both infertile and fertile, in China. Our results revealed that U. urealyticum, but not M. hominis, can negatively influence the seminal quality. Therefore, clinicians should pay close attention to these infections, particularly U. urealyticum infection, in infertile men. Our antibiotic susceptibility test results indicate that doxycycline and josamycin should be the primary choice in the empirical treatment of these infections.
References
Practice Committee of the American Society of Reproductive Medicine (2013) Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 99:63
Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J et al (1991) Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988–1989). Hum Reprod 6:811–816
Keck C, Gerber-Schafer C, Clad A, Wilhelm C, Breckwoldt M (1998) Seminal tract infections: impact on male fertility and treatment options. Hum Reprod Update 4:891–903
Leli C, Mencacci A, Bombaci JC, D’Alo F, Farinelli S, Vitali M et al (2012) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Infez Med 20:82–87
Zhang N, Wang R, Li X, Liu X, Tang Z, Liu Y (2014) Are Ureaplasma spp. a cause of nongonococcal urethritis? A systematic review and meta-analysis. PLoS ONE 9:e113771
Tibaldi C, Cappello N, Latino MA, Masuelli G, Marini S, Benedetto C (2009) Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect 15:670–679
Lanzafame M, Delama A, Lattuada E, Faggian F, Padovani GC, Concia E et al (2006) Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. Infez Med 14:213–215
Murtha AP, Edwards JM (2014) The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin North Am 41:615–627
Andrade-Rocha FT (2003) Ureaplasma urealyticum and Mycoplasma hominis in men attending for routine semen analysis. Prevalence, incidence by age and clinical settings, influence on sperm characteristics, relationship with the leukocyte count and clinical value. Urol Int 71:377–381
Wang Y, Liang CL, Wu JQ, Xu C, Qin SX, Gao ES (2006) Do Ureaplasma urealyticum infections in the genital tract affect semen quality? Asian J Androl 8:562–568
Liu J, Wang Q, Ji X, Guo S, Dai Y, Zhang Z et al (2014) Prevalence of Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis infections, and semen quality in infertile and fertile men in China. Urology 83:795–799
Lee JS, Kim KT, Lee HS, Yang KM, Seo JT, Choe JH (2013) Concordance of Ureaplasma urealyticum and Mycoplasma hominis in infertile couples: impact on semen parameters. Urology 81:1219–1224
Gunyeli I, Abike F, Dunder I, Aslan C, Tapisiz OL, Temizkan O (2011) Chlamydia, Mycoplasma and Ureaplasma infections in infertile couples and effects of these infections on fertility. Arch Gynecol Obstet 283:379–385
Chen XS, Gong XD, Liang GJ, Zhang GC (2000) Epidemiologic trends of sexually transmitted diseases in China. Sex Transm 27:138–142
Chen XS, Peeling RW, Yin YP, Mabey DC (2010) The epidemic of sexually transmitted infections in China: implications for control and future perspectives. BMC Med 9:111
Zeighami H, Peerayeh SN, Yazdi RS, Sorouri R (2009) Prevalence of Ureaplasma urealyticum and Ureaplasma parvum in semen of infertile and healthy men. Int J STD AIDS 20:387–390
Zhang Q, Xiao Y, Zhuang W, Cheng B, Zheng L, Cai Y et al (2014) Effects of biovar I and biovar II of Ureaplasma urealyticum on sperm parameters, lipid peroxidation, and deoxyribonucleic acid damage in male infertility. Urology 84:87–92
Zhang Z, Zhong J, Chen W (2014) Research of male infertility and urogenital mycoplasma infection. Heilongjiang Med J 38:451–452
Huang C, Peng L, Zheng Z, Jiang Y (2014) Value of detection of Mycoplasma, Chlamydia and anti-sperm antibodies in male infertility. Int J Lab Med 35:1412–1414
Uuskula A, Kohl PK (2002) Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. Int J STD AIDS 13:79–85
Potts JM, Sharma R, Pasqualotto F et al (2000) Association of Ureaplasma urealyticum with abnormal reactive oxygen species levels and absence of leukocytospermia. J Urol 163:1775–1778
Zeng L, Zou Q, Jing W, Luo X (2013) Analysis of mycoplasma infection and drug susceptibility result in male infertile patients. J Mod Med Health 29:1460–1461
Gdoura R, Kchaou W, Ammar-Keskes L, Chakroun N, Sellemi A, Znazen A et al (2008) Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl 29:198–206
Gdoura R, Kchaou W, Chaari C, Znazen A, Keskes L, Rebai T et al (2007) Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men. BMC Infect Dis 7:129
Sanocka-Maciejewska D, Ciupinska M, Kurpisz M (2005) Bacterial infection and semen quality. J Reprod Immunol 67:51–56
Al-Sweih NA, Al-Fadli AH, Omu AE, Rotimi VO (2012) Prevalence of Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections and seminal quality in infertile and fertile men in Kuwait. J Androl 33:1323–1329
Koh E, Kim S, Kim I, Maeng K, Lee S (2009) Antimicrobial susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in pregnant women. Korean J Clin Microbiol 12:159–162
Yang Y, Yuan M, Zhang YH, Wang XX (2014) Mycoplasma causing urogenital tract infections and analysis of drug susceptibility. Chin J Nosocomiol 24:316–317
Chen AH, Tao J, Du ZQ, Deng Q, Zuo MZ, Zheng WF (2015) Clinical mycoplasma infections in infertility patients. Chin J Nosocomiol 25:2379–2381
Yang C, Zhao Q (2015) Analysis of 726 patients with mycoplasma infection and drug sensitivity. Med Sci J Central South China 43:192–194
Acknowledgments
This work was supported by the Fundamental Research Funds for the Central Universities of Central South University (2015zzts102).
Author contributions
Huang C involved in project development, data analysis, and proof reading and wrote the manuscript. Long XY wrote the manuscript and involved in data collection and analysis. Jing S, Xu KR, and Wang SY edited the manuscript and involved in proof reading. Fan LQ and Zhu WB involved in project development.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Huang, C., Long, X., Jing, S. et al. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China. World J Urol 34, 1039–1044 (2016). https://doi.org/10.1007/s00345-015-1724-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1724-z